Profile change history

What changed for LL-37?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed LL-37 identity.

32Total events
31Record additions
1Version changes
7Cited source years

Before and after

Preserved version changes

Profile updated

LL-37 profile

We added three randomized trials of LL-37 in chronic ulcers, FDA’s advisory committee page listing LL-37 for a meeting before the end of February 2027, and the spelling LL37 that trial registrations use, so that those registrations are matched.

PeptideScanner change date
November 16, 2026
Evidence lane
Profile

Profile summary

Before
A 37-amino-acid human cathelicidin peptide, also called ropocamptide, that FDA lists among compounding substances that may present significant safety risks.
After
A 37-amino-acid human cathelicidin peptide, also called ropocamptide, tested in small trials in chronic ulcers. FDA lists it among compounding substances that may present significant safety risks.

Evidence note

Before
FDA states that it lacks sufficient safety information on LL-37 in people and cites nonclinical findings of harm to male reproduction and tumor promotion. LL-37 is not among the six peptides in HHS’s October 2026 draft enforcement-discretion policy.
After
Three small randomized trials in chronic leg and foot ulcers report mixed results; the largest found no significant difference from placebo. FDA states that it lacks sufficient safety information on LL-37 in people. LL-37 is not among the six peptides in HHS’s October 2026 draft enforcement-discretion policy.

Related names

Before
Cathelicidin LL-37, Ropocamptide
After
Cathelicidin LL-37, Ropocamptide, LL37

Cited source records

Before
fda-ll-37-identity, fda-bulk-peptide-risks, hhs-503a-peptide-enforcement-discretion-notice-2026, hhs-503a-peptide-enforcement-discretion-policy-2026
After
fda-ll-37-identity, fda-bulk-peptide-risks, hhs-503a-peptide-enforcement-discretion-notice-2026, hhs-503a-peptide-enforcement-discretion-policy-2026, fda-pcac-503a-meeting-2027, journal-pmid-25041740, journal-pmid-34687253, journal-pmid-37480520, ctg-observation-nct02225366-2021-12-09-d146b413ecf5

Claim citations

Before
name: fda-ll-37-identity, fda-bulk-peptide-risks; aliases: fda-ll-37-identity; category: fda-bulk-peptide-risks; status: fda-bulk-peptide-risks; summary: fda-ll-37-identity, fda-bulk-peptide-risks; evidenceNote: fda-bulk-peptide-risks, hhs-503a-peptide-enforcement-discretion-policy-2026
After
name: fda-ll-37-identity, fda-bulk-peptide-risks; aliases: fda-ll-37-identity; category: fda-bulk-peptide-risks; status: fda-bulk-peptide-risks; summary: fda-ll-37-identity, fda-bulk-peptide-risks, journal-pmid-34687253; evidenceNote: journal-pmid-34687253, journal-pmid-25041740, journal-pmid-37480520, fda-bulk-peptide-risks, hhs-503a-peptide-enforcement-discretion-policy-2026

Collection chronology

Evidence added to PeptideScanner

Browse all 31 connected records →

Showing the latest 31 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 16, 2026.

Record added

ClinicalTrials.gov record NCT02225366

PeptideScanner retained ClinicalTrials.gov record NCT02225366 at 2026-11-16T16:10:17.145Z. Its registry update date was 2021-12-09, and PeptideScanner's reviewed identity mapping was ll-37.

PeptideScanner change date
November 16, 2026
Cited source date
December 9, 2021
Evidence lane
Clinical trials
Record added

Defensins and LL-37: a review of function in the gingival epithelium.

PubMed lists PMID 23931055 in Periodontology 2000 as Journal Article, Research Support, N.I.H., Extramural, Review, with publication-date metadata of 2013-10 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 15, 2024
Evidence lane
Literature metadata
Record added

High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.

PubMed lists PMID 24463069 in Biochimica et biophysica acta as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2014-01-23 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 7, 2022
Evidence lane
Literature metadata
Record added

[A review: the role of antimicrobial peptide LL-37 in chronic sinusitis].

PubMed lists PMID 24738326 in Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery as Journal Article, Review, with publication-date metadata of 2014-01 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 7, 2022
Evidence lane
Literature metadata
Record added

Antibacterial function of the human cathelicidin-18 peptide (LL-37) between theory and practice.

PubMed lists PMID 25101632 in Protein and peptide letters as Journal Article, Review, with publication-date metadata of 2014 (year precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 7, 2022
Evidence lane
Literature metadata
Record added

The Role of Cathelicidin LL-37 in Cancer Development.

PubMed lists PMID 26395996 in Archivum immunologiae et therapiae experimentalis as Journal Article, Review, with publication-date metadata of 2015-09-22 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 7, 2022
Evidence lane
Literature metadata
Record added

Unique features of human cathelicidin LL-37.

PubMed lists PMID 26434733 in BioFactors (Oxford, England) as Journal Article, Review, with publication-date metadata of 2015-10-05 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 7, 2022
Evidence lane
Literature metadata
Record added

LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity.

PubMed lists PMID 27117377 in Pharmacological reports : PR as Journal Article, Review, with publication-date metadata of 2016-04-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 7, 2022
Evidence lane
Literature metadata
Record added

The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease.

PubMed lists PMID 27135484 in Inflammatory bowel diseases as Journal Article, Review, with publication-date metadata of 2016-08 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 7, 2022
Evidence lane
Literature metadata
Record added

Circulating cathelicidin LL-37 in adult patients with pulmonary infectious diseases.

PubMed lists PMID 28218580 in Clinical and investigative medicine. Medecine clinique et experimentale as Clinical Trial, Journal Article, with publication-date metadata of 2017-02-19 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 7, 2022
Evidence lane
Literature metadata
Record added

Serum level of cathelicidin LL-37 in patients with active tuberculosis and other infectious diseases.

PubMed lists PMID 28956425 in Journal of biological regulators and homeostatic agents as Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2017 Jul-Sep (source-text precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 7, 2022
Evidence lane
Literature metadata
Record added

Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer.

PubMed lists PMID 29843147 in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology as Journal Article, Review, with publication-date metadata of 2018-05-25 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 7, 2022
Evidence lane
Literature metadata
Record added

Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37.

PubMed lists PMID 30980360 in Advances in experimental medicine and biology as Journal Article, Review, with publication-date metadata of 2019 (year precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 7, 2022
Evidence lane
Literature metadata
Record added

Performance evaluation of antimicrobial peptide ll-37 and hepcidin and β-defensin-2 secreted by mesenchymal stem cells.

PubMed lists PMID 31687504 in Heliyon as Journal Article, Review, with publication-date metadata of 2019-10-23 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 21, 2024
Evidence lane
Literature metadata
Record added

Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus.

PubMed lists PMID 32743514 in Journal of translational autoimmunity as Journal Article, Review, with publication-date metadata of 2019-12-17 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 28, 2020
Evidence lane
Literature metadata
Record added

Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections.

PubMed lists PMID 32927756 in Vaccines as Journal Article, Review, with publication-date metadata of 2020-09-10 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 12, 2023
Evidence lane
Literature metadata
Record added

Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures.

PubMed lists PMID 34068993 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2021-05-14 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 7, 2022
Evidence lane
Literature metadata
Record added

Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy.

PubMed lists PMID 36081952 in Frontiers in pharmacology as Journal Article, Review, with publication-date metadata of 2022-08-23 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 12, 2022
Evidence lane
Literature metadata
Record added

Antibiofilm properties of cathelicidin LL-37: an in-depth review.

PubMed lists PMID 36781570 in World journal of microbiology & biotechnology as Review, Journal Article, with publication-date metadata of 2023-02-14 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 30, 2026
Evidence lane
Literature metadata
Record added

Between good and evil: Complexation of the human cathelicidin LL-37 with nucleic acids.

PubMed lists PMID 37919905 in Biophysical journal as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-11-02 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 7, 2026
Evidence lane
Literature metadata
Record added

Antifungal properties of cathelicidin LL-37: current knowledge and future research directions.

PubMed lists PMID 38057654 in World journal of microbiology & biotechnology as Journal Article, Review, with publication-date metadata of 2023-12-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 31, 2026
Evidence lane
Literature metadata
Record added

LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases.

PubMed lists PMID 38540740 in Biomolecules as Journal Article, Review, Research Support, N.I.H., Extramural, with publication-date metadata of 2024-03-08 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
April 16, 2026
Evidence lane
Literature metadata
Record added

[Progress of researches on the antiparasitic activity of antimicrobial peptide LL-37].

PubMed lists PMID 38604693 in Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control as Review, English Abstract, Journal Article, with publication-date metadata of 2024-03-25 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
April 30, 2024
Evidence lane
Literature metadata
Record added

Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease.

PubMed lists PMID 39615616 in Pharmacological research as Journal Article, Review, with publication-date metadata of 2024-11-28 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 17, 2025
Evidence lane
Literature metadata
Record added

LL-37, the master antimicrobial peptide, its multifaceted role from combating infections to cancer immunity.

PubMed lists PMID 39643165 in International journal of antimicrobial agents as Journal Article, Review, with publication-date metadata of 2024-12-04 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 7, 2025
Evidence lane
Literature metadata
Record added

Cathelicidin LL-37 in periodontitis: current research advances and future prospects - A review.

PubMed lists PMID 39954662 in International immunopharmacology as Journal Article, Review, with publication-date metadata of 2025-02-15 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 7, 2025
Evidence lane
Literature metadata
Record added

Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications.

PubMed lists PMID 40869425 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2025-08-21 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 31, 2025
Evidence lane
Literature metadata
Record added

Significance of the LL-37 Peptide Delivered from Human Cathelicidin in the Pathogenesis, Treatment, and Diagnosis of Sepsis.

PubMed lists PMID 40960088 in Archivum immunologiae et therapiae experimentalis as Journal Article, Review, with publication-date metadata of 2025-09-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 17, 2025
Evidence lane
Literature metadata
Record added

Decoding LL-37: Structure and antimicrobial mechanisms against microbial threats.

PubMed lists PMID 41270816 in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases as Journal Article, Review, with publication-date metadata of 2025-11-19 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 15, 2025
Evidence lane
Literature metadata
Record added

LL-37: Biological Mechanisms and Emerging Therapeutic Applications in Intestinal Disease.

PubMed lists PMID 42095322 in Immunity, inflammation and disease as Journal Article, Review, with publication-date metadata of 2026-05 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 21, 2026
Evidence lane
Literature metadata
Record added

LL-37-MRGPRX2-Mast Cell Signaling in Rosacea: Current Evidence and Directions for Human Studies.

PubMed lists PMID 42861262 in Clinical, cosmetic and investigational dermatology as Journal Article, Review, with publication-date metadata of 2026-10-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 13, 2026
Evidence lane
Literature metadata